Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
The duration of antibiotic treatment of exacerbations of COPD (ECOPD) is controversial. Serum procalcitonin (PCT) is a biomarker of bacterial infection used to identify the cause of ECOPD.We investigated whether a PCT-guided plan would allow a shorter duration of antibiotic treatment in patients wit...
Main Authors: | Alessia Verduri, Fabrizio Luppi, Roberto D'Amico, Sara Balduzzi, Roberto Vicini, Anna Liverani, Valentina Ruggieri, Mario Plebani, Maria Pia Foschino Barbaro, Antonio Spanevello, Giorgio Walter Canonica, Alberto Papi, Leonardo Michele Fabbri, Bianca Beghè, FARM58J2XH Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4356612?pdf=render |
Similar Items
-
Noninferiority trials
by: Snapinn Steven M
Published: (2000-07-01) -
Understanding noninferiority trials
by: Seokyung Hahn
Published: (2012-11-01) -
Noninferior set scenario analysis
by: McCahon, Oliver Colin
Published: (2010) -
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
by: Gladstone BP, et al.
Published: (2015-01-01) -
Understanding superiority, noninferiority, and equivalence for clinical trials
by: Kamal Kishore, et al.
Published: (2020-01-01)